References
- Dalakas MC, Karpati G. Inflammatory myopathies. In: Karpati G, Hilton-Jones D, Griggs RC, eds. Disorders of voluntary muscles. 7th ed. Cambridge: Cambridge University Press; 2001:636–59.
- Marie I, Mouthon L. Therapy of polymyositis and dermatomyositis. Autoimmun Rev. 2011;11:6–13.
- Hak AE, de Paepe B, de Bleecker JL, Tak PP, de Visser M. Dermatomyositis and polymyositis: new treatment targets on the horizon. Neth J Med. 2011;69:410–21.
- Dalakas MC. Pathophysiology of inflammatory and autoimmune myopathies. Presse Med. 2011;40:237–47.
- Marie I. Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep. 2012;14:275–85.
- Ohta A, Nagai M, Nishina M, Tomimitsu H, Kohsaka H. Age at onset and gender distribution of systemic lupus erythematosus, polymyositis/dermatomyositis, and systemic sclerosis in Japan. Mod Rheumatol. 2013;23:759–64.
- Ohta A, Nagai M, Nishina M, Tomimitsu H, Kohsaka H. Prevalence and Incidence of polymyositis and dermatomyositis in Japan. Mod Rheumatol. 2014;24:477–80.
- Tamakoshi A, Ohno Y, Sasaki R, Kubo N, Hashimoto S, Nakamura T, et al. Estimation of the number of patients with intractable diseases from a nationwide epidemiologic survey (in Japanese). Nihon Ijishinpo. 1993;3610:49–52.
- Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995;22:668–74.
- Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.
- Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol. 2006;25:234–9.